Compass Therapeutics, Inc.
CMPX
$5.30
-$0.02-0.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.22% | 28.28% | -19.53% | -10.64% | -43.46% |
| Total Depreciation and Amortization | -0.27% | 1.09% | 0.82% | 1.39% | -22.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.11% | -67.59% | 4.84% | 29.07% | 2.50% |
| Change in Net Operating Assets | -32.77% | -56.64% | 863.34% | -85.30% | 219.85% |
| Cash from Operations | -22.17% | 8.31% | 10.42% | -44.16% | 17.09% |
| Capital Expenditure | 100.00% | -- | 100.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.45% | -1,396.05% | -154.80% | -24.49% | -47.11% |
| Cash from Investing | 96.45% | -1,396.16% | -154.88% | -24.61% | -47.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.08% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -748.96% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | 200.00% |
| Cash from Financing | -99.18% | -- | 100.00% | -767.02% | -4,600.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -166.66% | 228.39% | -647.10% | -136.44% | -62.81% |